Manulife (Manufacturers Life Insurance)
MRNS

Manulife (Manufacturers Life Insurance)’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-20,119
Closed -$182K – 3086
2024
Q1 		$182K Buy
20,119
+84
+0.4% +$817 ﹤0.01% 2627
2023
Q4 		$218K Hold
20,035
– – ﹤0.01% 2584
2023
Q3 		$161K Buy
20,035
+41
+0.2% +$341 ﹤0.01% 2670
2023
Q2 		$217K Buy
+19,994
New +$171K ﹤0.01% 2564
2022
Q2 		– Sell
-16,115
Closed -$151K – 3186
2022
Q1 		$151K Sell
16,115
-4,451
-22% -$44.2K ﹤0.01% 2866
2021
Q4 		$244 Buy
20,566
+305
+2% +$3.52K ﹤0.01% 2772
2021
Q3 		$231K Sell
20,261
-1,045
-5% -$14.4K ﹤0.01% 2879
2021
Q2 		$382K Buy
21,306
+4,050
+23% +$65.2K ﹤0.01% 2619
2021
Q1 		$267K Buy
17,256
+1,430
+9% +$20.7K ﹤0.01% 2689
2020
Q4 		$193K Buy
15,826
+930
+6% +$13K ﹤0.01% 2794
2020
Q3 		$191K Buy
14,896
+1,600
+12% +$13.8K ﹤0.01% 2590
2020
Q2 		$133K Buy
13,296
+901
+7% +$8.29K ﹤0.01% 2655
2020
Q1 		$101K Buy
+12,395
New +$107K ﹤0.01% 2576
2019
Q3 		– Sell
-8,686
Closed -$144K – 2936
2019
Q2 		$144K Buy
8,686
+330
+4% +$5.73K ﹤0.01% 2791
2019
Q1 		$140K Buy
8,356
+2,142
+34% +$30.8K ﹤0.01% 2518
2018
Q4 		$71K Sell
6,214
-318
-5% -$6.43K ﹤0.01% 2470
2018
Q3 		$261K Sell
6,532
-934
-13% -$26.6K ﹤0.01% 2603
2018
Q2 		$211K Buy
7,466
+7,063
+1,753% +$157K ﹤0.01% 3091
2018
Q1 		$6K Buy
403
+36
+10% +$857 ﹤0.01% 4079
2017
Q4 		$12K Buy
+367
New +$9.89K ﹤0.01% 3935
2017
Q2 		– Sell
-40
Closed – – 4477
2017
Q1 		$0 Hold
40
– – ﹤0.01% 4424
2016
Q4 		$0 Hold
40
– – ﹤0.01% 4475
2016
Q3 		$0 Hold
40
– – ﹤0.01% 4374
2016
Q2 		$0 Hold
40
– – ﹤0.01% 4350
2016
Q1 		$1K Buy
+40
New +$848 ﹤0.01% 4041
2015
Q3 		– Sell
-41
Closed -$2 – 4121
2015
Q2 		$2 Hold
41
– – ﹤0.01% 3837
2015
Q1 		$1 Hold
41
– – ﹤0.01% 3917
2014
Q4 		$2 Buy
+41
New +$1.19K ﹤0.01% 3763

Other funds holding MRNS

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s MRNS Position: Q2 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2024, closing a stake of 20,119 shares — an estimated $182K sold.

Manulife (Manufacturers Life Insurance) first reported a position in MRNS in Q4 2014 and held it in 28 quarters. The position peaked at $382K in Q2 2021. 90 funds tracked by Wall St. Rank hold MRNS as of Q2 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 20,119 Marinus Pharmaceuticals, Inc shares in Q2 2024, an estimated $182K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Marinus Pharmaceuticals, Inc in Q4 2014 and held it in 28 quarters.
  • Manulife (Manufacturers Life Insurance)'s Marinus Pharmaceuticals, Inc position peaked at $382K in Q2 2021.
  • 90 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2024, filed 14 Aug 2024.